Overall, our analyses illustrate ICI-mediated release of T cell checkpoint engagement of tumor-specific, PD1+ TOX+ CD8 T cells upregulates CXCL13, which subsequently recruits CXCR5+ B cells and Tfh to form TLS in the TME. Here, CXCR5 is linked to neoplasm.